Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Margalit

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Autoimmunity|January 5, 2002
Self prion protein peptides are immunogenic in Lewis ratsL Souan, R Margalit, O Brenner, et al.
Journal of Autoimmunity|October 21, 2000
Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulinsA Achiron, F Mor, R Margalit, et al.
Enzyme and Microbial Technology|October 1, 1996
Comparison of the properties of native and pentaammineruthenium(III)-modified xylanaseB R Evans, L M Lane, R Margalit, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrixJ Kaminchik, R Margalit, S Yaish, et al.
Journal of Community Health|January 23, 2013
Lakota elders' views on traditional versus commercial/addictive tobacco use; oral history depicting a fundamental distinctionR Margalit, S Watanabe-Galloway, F Kennedy, et al.
The Journal of Clinical Investigation|February 1, 1994
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretionA Achiron, R Margalit, R Hershkoviz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanaseO Lider, L Cahalon, D Gilat, et al.
Inflammatory Bowel Diseases|March 12, 2010
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in miceN Maharshak, G Hart, E Ron, et al.
International Immunology|November 14, 1997
Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodentsL Cahalon, O Lider, H Schor, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
The 60-kDa heat shock protein modulates allograft rejectionO S Birk, S L Gur, D Elias, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Autoimmunity|January 5, 2002
Self prion protein peptides are immunogenic in Lewis ratsL Souan, R Margalit, O Brenner, et al.
Journal of Autoimmunity|October 21, 2000
Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulinsA Achiron, F Mor, R Margalit, et al.
Enzyme and Microbial Technology|October 1, 1996
Comparison of the properties of native and pentaammineruthenium(III)-modified xylanaseB R Evans, L M Lane, R Margalit, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrixJ Kaminchik, R Margalit, S Yaish, et al.
Journal of Community Health|January 23, 2013
Lakota elders' views on traditional versus commercial/addictive tobacco use; oral history depicting a fundamental distinctionR Margalit, S Watanabe-Galloway, F Kennedy, et al.
The Journal of Clinical Investigation|February 1, 1994
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretionA Achiron, R Margalit, R Hershkoviz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanaseO Lider, L Cahalon, D Gilat, et al.
Inflammatory Bowel Diseases|March 12, 2010
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in miceN Maharshak, G Hart, E Ron, et al.
International Immunology|November 14, 1997
Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodentsL Cahalon, O Lider, H Schor, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999
The 60-kDa heat shock protein modulates allograft rejectionO S Birk, S L Gur, D Elias, et al.
Pageof 8